London – October 1, 2025 – The United Kingdom’s flagship FTSE 100 share index has achieved a new intraday record high at the start of trading today, brushing aside concerns surrounding the unfolding US government shutdown. The index climbed 32 points to 9382, signalling robust investor confidence in the London market despite geopolitical uncertainties across the Atlantic.
This significant milestone caps a strong year for UK equities, with the FTSE 100 posting its best quarterly gain since the final quarter of 2022, adding a remarkable 6.7% between July and September 2025. The positive momentum has carried into the new month, as investors appear to be adopting a resilient stance towards the US political situation.
A New Peak Amidst Global Uncertainty
The FTSE 100 reached a new intraday high of 9382 points on Wednesday morning, surpassing its previous record. This surge occurred even as the US government officially entered a shutdown, a situation that historically can introduce market volatility. The market’s ability to look beyond this immediate political event highlights a broader optimism surrounding the UK economy and its leading companies.
Several factors are contributing to the FTSE 100’s upward trajectory in 2025. Demand has been particularly strong in sectors such as defense, mining, and banking. This broad-based strength suggests a healthy market underpinned by diversified economic activity rather than reliance on a single growth driver.
Pharma Giants Lead the Charge
Among the day’s top performers were pharmaceutical heavyweights AstraZeneca and Hikma. AstraZeneca saw its shares rise by 3.6%, while Hikma Pharmaceuticals experienced a 3.2% increase in early trading. These gains were partly attributed to news of the US government agreeing to its first “most favoured nation” drug pricing deal with Pfizer, a development that appeared to buoy the broader pharmaceutical sector. GlaxoSmithKline also saw a notable increase in its share price.
Investors Shrug Off US Shutdown Precedents
The market’s apparent nonchalance towards the US government shutdown is not without historical precedent. While shutdowns can introduce uncertainty and delay economic data releases, past events have often proven to be temporary disruptions with limited long-term economic impact. For instance, the significant shutdown in 2018-2019, which lasted over a month, did not derail Wall Street’s overall performance. Investors seem to be factoring in the likelihood of a relatively short duration for the current shutdown and focusing instead on more fundamental economic indicators and corporate performance.
The Broader Picture for UK Equities
Analysts have expressed optimism for UK equities in 2025, citing attractive valuations compared to global peers and compelling income streams from dividends, which can offer a hedge against inflation. While the global economic environment remains complex, with ongoing geopolitical tensions and consumer demand tempered by high interest rates, the UK market is seen as offering opportunities.
The FTSE 100’s performance in the third quarter of 2025 was particularly strong, with a 6.7% gain. This quarter has been the index’s best since October-December 2022. Looking ahead, forecasts for the FTSE 100 in 2025 have varied, but the general sentiment suggests a steady performance, supported by defensive sectors. The prospect of potential interest rate cuts by the Bank of England also presents a supportive factor for the UK stock market.
Economic Data and Future Outlook
While the US government shutdown might disrupt the release of crucial economic data, such as the nonfarm payrolls report, market participants will likely turn their attention to other available indicators. The UK’s economic performance has also shown resilience, with GDP growth ticking higher in the second quarter of 2025, albeit at a slower rate than in the previous quarter.
In conclusion, the FTSE 100’s reach to a new record high on October 1, 2025, underscores the market’s current resilience. Despite the US government shutdown, a combination of strong quarterly performance, the robust showing of key sectors like pharmaceuticals, and a generally positive outlook for UK equities in 2025 have propelled the index to new heights. Investors appear to be prioritizing economic fundamentals and corporate strength over immediate political uncertainties, setting an optimistic tone for the beginning of the fourth quarter. This news from London provides a notable feature in the day’s financial reporting.
